“…In particular, in the striatum of adult and old rats, changes in Nurr1 gene expression and reduced dopamine (DA) level together with its accelerated turnover were observed [ 9 , 10 , 11 , 12 ]. Moreover, oxidative stress, high plasma NO production, protein and lipid oxidation, low GSH levels were measured [ 13 ]. In the same model, we demonstrated that PERM accumulates in the brain later after the end of treatment, and that early life exposure can modify DNA methyltransferases and alfa-synuclein, suggesting that PERM might mediate genetic and epigenetic modifications leading to development of neurological disorders with some typical features of Parkinson’s-like disease [ 7 , 9 , 10 , 12 , 14 , 15 ].…”